Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diagnostic impact of tau versus amyloid PET in patients with cognitive symptoms.

Brain : a journal of neurology·2026
Same author

Assessment of clinical and neuroimaging efficacy of treatment targeting tau pathology in mild cognitive impairment and mild to moderate Alzheimer's disease with hydromethylthionine mesylate using external control data.

The journal of prevention of Alzheimer's disease·2026
Same author

Atypical population pharmacokinetics of hydromethylthionine in patients with Alzheimer's disease explains unexpected phase 3 trial results.

British journal of clinical pharmacology·2026
Same author

A Cross-sectional Case-control Study on Metacognition, Neurocognitive Functions, and Quality of Life Among Older Adults with Depressive Disorder.

Indian journal of psychological medicine·2026
Same author

Effect of Low-dose Escitalopram on Cognition and Behavior of Patients With Dementia Without Depression: A Retrospective Study.

Clinical neuropharmacology·2026
Same author

Timing matters: early administration of a high-affinity antibody targeting the tau repeat domain prevents aggregation in a mouse tauopathy model.

Alzheimer's research & therapy·2026
Same journal

Current Status of PSMA-Targeted Agents Based on Small Molecules for Prostate Cancer in Preclinical Studies.

Nuclear medicine and molecular imaging·2026
Same journal

Fibroblast Activation Protein-Targeted SPECT Imaging Using <sup>99m</sup>Tc: A Comprehensive Review.

Nuclear medicine and molecular imaging·2026
Same journal

The 2026 Special Issue on Radiopharmaceuticals: from Molecular Design to Clinical Translation.

Nuclear medicine and molecular imaging·2026
Same journal

Feasibility of [<sup>99m</sup>Tc]Tc-Mannosylated Human Serum Albumin for Lymphoscintigraphy: A Phase 1/2 Clinical Trial.

Nuclear medicine and molecular imaging·2026
Same journal

Automated Synthesis of Radiopharmaceuticals: Technology, Applications, and Regulatory Perspectives.

Nuclear medicine and molecular imaging·2026
Same journal

Development of Antibody and Antibody Fragment-Based Radiopharmaceuticals for Cancer Imaging and Therapy.

Nuclear medicine and molecular imaging·2026
See all related articles

Related Experiment Video

Updated: May 21, 2025

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
05:17

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451

Published on: April 18, 2025

76

FDG-PET Image Classification in Alzheimer's Disease: from Traditional Visual Analysis to Advanced Transfer Learning.

Shailendra Mohan Tripathi1,2, Christopher J McNeil3, Roger T Staff4

  • 1Department of Geriatric Mental Health, King George's Medical University, UP, Lucknow India.

Nuclear Medicine and Molecular Imaging
|May 19, 2025
PubMed
Summary
This summary is machine-generated.

This study successfully classified Alzheimer's disease (AD) subtypes using 18F-Flouro-Deoxy-Glucose-Positron Emission Tomography (FDG-PET) scans. Machine learning achieved high accuracy in differentiating typical AD from mixed patterns, aiding diagnosis.

Keywords:
Alzheimer’s diseaseAutomated techniquesSemi-quantitative methodsTransfer learningVisual analysis

More Related Videos

Author Spotlight: Advancing Alzheimer's Research &#8211; Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

931
Non-invasive Imaging and Analysis of Cerebral Ischemia in Living Rats Using Positron Emission Tomography with 18F-FDG
10:31

Non-invasive Imaging and Analysis of Cerebral Ischemia in Living Rats Using Positron Emission Tomography with 18F-FDG

Published on: December 28, 2014

13.8K

Related Experiment Videos

Last Updated: May 21, 2025

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
05:17

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451

Published on: April 18, 2025

76
Author Spotlight: Advancing Alzheimer's Research &#8211; Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

931
Non-invasive Imaging and Analysis of Cerebral Ischemia in Living Rats Using Positron Emission Tomography with 18F-FDG
10:31

Non-invasive Imaging and Analysis of Cerebral Ischemia in Living Rats Using Positron Emission Tomography with 18F-FDG

Published on: December 28, 2014

13.8K

Area of Science:

  • Neuroimaging
  • Medical Diagnostics
  • Artificial Intelligence in Medicine

Background:

  • Alzheimer's disease (AD) often presents with co-existing brain pathologies.
  • Distinguishing AD subtypes is crucial for understanding disease heterogeneity and progression.
  • 18F-Flouro-Deoxy-Glucose-Positron Emission Tomography (FDG-PET) is a key imaging modality for assessing brain metabolism.

Purpose of the Study:

  • To classify individuals with Alzheimer's disease (AD) into distinct subtypes using FDG-PET imaging.
  • To differentiate between "typical AD" (temporoparietal hypometabolism) and "mixed" AD patterns.
  • To evaluate the efficacy of automated classification using transfer learning against visual interpretation.

Main Methods:

  • Collected baseline FDG-PET data from 794 probable AD subjects in Phase III clinical trials.
  • Visually classified FDG-PET images into "typical AD" and "mixed" patterns.
  • Employed region-of-interest analysis and transfer learning for automated classification and validation.

Main Results:

  • Of 794 participants, 533 were classified as typical AD and 261 as mixed AD.
  • Transfer learning achieved high accuracy (97.5% average) and performance metrics (sensitivity 94.73%, specificity 95.23%) in cross-validation.
  • Visual classification served as the gold standard for validating the automated approach.

Conclusions:

  • This study pioneers the distinction of AD subtypes using visual FDG-PET interpretation.
  • Semi-quantitative analysis and transfer learning effectively identified AD subtypes with high accuracy.
  • The findings demonstrate the potential of FDG-PET and AI for precise AD subtyping and diagnosis.